TLX ▼ -0.7% - Telix Pharmaceuticals Limited
$TLX - First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)
06-OCT-2026 06:30 AM ET
Share this post
More filings for $TLX
TLX ▲ +1.5% - Telix Pharmaceuticals LimitedSep 21, 2026TLX ▲ +9.2% - Telix Pharmaceuticals LimitedSep 14, 2026TLX ▼ -0.4% - Telix Pharmaceuticals LimitedSep 1, 2026TLX ▼ -2.0% - Telix Pharmaceuticals LimitedAug 31, 2026
View full $TLX filing history →💬 Comments
Loading comments…
Leave a comment